IRIDEX Corporation (Nasdaq: IRIX) today announced the introduction of the IQ 532(TM) dual-port ophthalmic green laser photocoagulator which will be featured at the 2009 American Academy of Ophthalmology meeting in San Francisco.
"The IQ 532 represents the latest addition to the IRIDEX family of IQ laser systems," commented Theodore A. Boutacoff, President & CEO. "With the IQ 532, physicians can perform a wide range of clinical applications using the latest solid-state laser technology with two notable new features. One is dual-port laser output. Physicians may connect a delivery device to each laser port and then switch between devices without changing connections. Another is the user interface featuring: an easy to use touchscreen with options for storing system presets such as physician treatment settings; and voice confirmation. Both features add convenience and save time by accelerating system setup and operation."
The IQ 532 is the eighth ophthalmic laser in IRIDEX' current product line of laser photocoagulators each tailored to satisfy specific needs of the ophthalmic surgeon. The IQ 532 adds to the portfolio of photocoagulator systems known for their high quality and reliability, as well as efficient designs for quick and effective depot servicing.
AI-READI consortium launches groundbreaking diabetes data study